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Abstract
Glutamate receptors of the kainate type (Kainate receptors, KARs), are media-
tors of ionotropic postsynaptic synaptic transmission, as well as presynaptic 
modulators of neurotransmitter release where they show both ionotropic and 
metabotropic actions regulating glutamate and γ-aminobutiric acid (GABA) release. 
The mechanisms underlying these modulatory roles are starting to be understood at 
some brain regions. Here we review the KARs roles and mechanisms involved in the 
modulation of glutamate release in the cerebellum at parallel fibers (PF)-Purkinje 
Cells (PuC) synapses. KARs activation mediate a biphasic effect on glutamate 
release at this synapse, with low kainate (KA) concentrations mediating a facilita-
tion of glutamate release and higher KA concentrations mediating a depression of 
glutamate release. KA-mediated facilitation is prevented by antagonizing KARs, 
by inhibition of PKA or stimulation of adenylyl cyclase (AC), by blocking Ca2+ 
permeant KARs, by depleting intracellular Ca2+ stores and by blocking calmodulin. 
Thus, at cerebellar parallel fiber-Purkinje cell synapses, presynaptic KARs medi-
ate glutamate release facilitation through Ca2+-calmodulin dependent activation 
of adenylyl cyclase/cAMP/protein kinase A signaling. KAR-mediated depression 
of glutamate release involves the AC/cAMP/PKA pathway as for facilitation but 
not Ca2+-calmodulin, being in this case AC activated by a Gi/o protein to mediate a 
depression of glutamate release.
Keywords: cerebellum, KARs, glutamate release, presynaptic, PKA, adenylate 
cyclase, Ca2+ calmodulin
1. Introduction
Glutamate is the most abundant excitatory neurotransmitter in the central 
nervous system (CNS) of mammals. Glutamate mediates its actions by activating 
glutamate receptors. These receptors participate in normal synaptic transmission at 
different synapses, in plasticity processes as long-term potentiation (LTP) and long-
term depression (LTD) that are considered the cellular and molecular correlation 
of memory and learning processes and in synaptogenesis and neuronal maturation 
and, additionally, failure in the functioning of this system can be the origin of some 
types of epilepsy and may contribute to the development of CNS disorders such as 
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Alzheimer’s disease, Huntington’s Korea, amyotrophic lateral sclerosis, Parkinson’s 
disease, hypoglycemia, or cerebral ischemia [1–3].
Glutamate receptors are classically divided into two large families: ionotropic 
and metabotropic. Ionotropic glutamate receptors (iGluRs) participate in rapid 
neurotransmission in the nervous system; these ionotropic receptors are classified 
into three types depending on the agonist that activates them with higher affinity: 
N-methyl-d-aspartic acid (NMDA) receptors (NMDARs), α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs), and kainate 
receptors (KARs). These receptors form a channel with different selectivity 
depending on their subunit composition, all of them being permeable to Na+ and 
K+ and, additionally, NMDARs are permeable to Ca2+ been some AMPARs and 
KARs also permeable to Ca2+ depending on subunit composition. They are inte-
gral membrane proteins, formed by four subunits (tetramers), being homomers 
or heteromers [1, 2].
Metabotropic glutamate receptors (mGluRs), which participate also in 
neurotransmission, are coupled to G proteins and are divided into eight types 
(mGluR 1–8) and three groups of receptors: group I mGluRs includes mGluR1 
and mGluR5 receptors. These receptors are positively coupled to phospholipase C 
(PLC), which facilitates the conversion of inositol diphosphate (PIP2) to diacyl-
glycerol (DAG) and inositol triphosphate (IP3). DAG activates protein kinase C 
(PKC) that phosphorylates different substrates and IP3 causes numerous intra-
cellular effects, including the facilitation of Ca2+ release from intracellular stores. 
Group II mGluRs includes mGluR2 and mGluR3 receptors. These receptors are 
negatively coupled to adenylate cyclase-mediated AMPc formation, and group 
III mGluRs includes mGluR4, mGluR6, mGluR7, and mGluR8 receptors. These 
receptors are negatively coupled to the formation of AMPc mediated by adenyl-
ate cyclase [4].
1.1 Kainate receptors
Kainate (KA) is a potent neurotoxin derived from the alga Digenea simplex. The 
word “Kainic” is derived from the Japanese “Kaininso” (“Makuri”), which means 
“the ghost of the sea,” and it is an agonist for both KARs and AMPARs (in the same 
way that the AMPARs agonist AMPA may activate KARs). Kainate is classically 
known for its potent epileptogenic actions [5, 6].
KA (and other agonists) activates KARs that are tetramers that resulted from 
different combinations of five subunits called GluK1, GluK2, GluK3, GluK4, and 
GluK5 (formerly known as GluR5, GluR6, GluR7 and KA1, and KA2, respectively). 
Of these subunits, GluK1 and GluK3 may form homomeric or heteromeric func-
tional receptors, while GluK4 and GluK5 may only participate in functional recep-
tors when associated with any of the GluK1, GluK2, or GluK3 subunits, but they do 
not combine with subunits of AMPARs [1, 7, 8].
KARs have been described in different invertebrates such as nematodes and 
flies [9, 10] and in different species of vertebrates such as amphibia, fish, and birds 
[11–13] in addition to mammals. In mammals, KARs have been observed virtually 
throughout the entire nervous system, although their subcellular location has not 
been yet fully determined. KARs are widely distributed throughout the CNS and 
found in the main cells and interneurons of the hippocampus, lateral amygdala, 
dorsal root ganglia, bipolar cells of the retina, cerebral cortex, and the cerebellum 
[14, 15].
The lack of knowledge about these receptors compared to other glutamatergic 
receptors (AMPARs or NMDARs) has been due to the lack of good agonist and 
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antagonist for receptors with particular subunit compositions and to the absence of 
specific antibodies for the different subunits of KARs, being therefore a significant 
limitation when exploring the distribution of these receptors. However, by using 
in situ hybridization techniques, it has been observed that the cells that present 
a significant expression of the kainate-type subunits GluK1, GluK2, GluK3, and 
GluK5 are distributed throughout the CNS, including nucleus striatum, hippocam-
pus, cortex, and cerebellum [16]. Likewise, there is a high expression of the GluK4 
subunit in the CA3 region of the hippocampus, as well as in the granular neurons of 
the dentate gyrus. The messenger of the GluK5 subunit, on the other hand, appears 
more abundantly and more extensively than that of the GluK4 subunit or those of 
the other subunits [15]. Because the in situ hybridization technique is informative 
and cannot reveal the subcellular distribution of a specific subunit, and because of 
pharmacological limitations, there is still much to know about the subcellular loca-
tion and physiology of these receptors.
Kainate-type glutamate receptors are well established mediators of canonical, 
ionotropic postsynaptic synaptic transmission and, presynaptically, have a modula-
tory role in regulating neurotransmitter release. In the latter regard, KARs have 
been shown to have a noncanonical metabotropic capacity, whereby they affect the 
control of both glutamate and GABA release, for review see [15, 17–22]. At some 
excitatory glutamatergic synapses, KARs’ activation can actually effect biphasic 
modulation, where low agonist concentrations facilitate glutamate release, while 
high concentrations decrease the release of the neurotransmitter, for review see 
[17, 18]. Mechanistic details of how this is achieved are subject of investigation and, 
indeed, the subcellular location of KARs responsible for presynaptic modulation 
remains contentious. Different roles of KARs in plasticity have also been described 
either in LTP or LTD, see [23] for a review of the role of KARs in plasticity.
As other glutamate receptors, KARs are directly or indirectly involved in dif-
ferent diseases, alterations of the nervous system and neurodegeneration and cell 
death processes. As previously indicated, KA is a potent neurotoxin that directly 
induces epilepsy and is used as a temporal lobe epilepsy model [5, 6]. Several lines 
of research indicate that KA directly activating KARs is involved in excitatory 
and inhibitory imbalances associated with epilepsy. The use of animal models for 
epilepsy through the use of KA injections has allowed to reproduce in great detail 
the symptoms observed in humans. The majority of studies of KARs’ involvement 
in epilepsy have studied acute KA-induced seizures [24–27]. The best demonstra-
tions of a mechanism for KARs’ involvement in acute epilepsy come from studies of 
inhibition of GABA release by the activation of presynaptic KA receptors at inter-
neuron-CA1 hippocampal synapses [24, 28, 29]. In chronic epilepsy, a role of KARs 
has been demonstrated at hippocampal mossy fibers making aberrant synapses onto 
granule cells of dentate gyrus expressing high number of KARs [30–32] reviewed 
in [6, 33]. In humans, genetic studies of members of a family affected by idiopathic 
juvenile absence epilepsy found elevated levels of Grik1 polymorphisms [34], and 
in TLE patients, GluK1 subunit containing KARs’ increased levels have also been 
found [35]. In clinical studies, NS1209 (an AMPA/KARs’ antagonist) has been 
found to decrease epileptic symptoms [36].
Different studies of neurotoxicity clearly indicate that KARs might be impor-
tant targets for neuroprotection in neurons and glial cells. The mechanism by 
which KARs produce excitotoxicity and neuronal cell death is not well understood 
mainly because of the limitations in appropriate pharmacological tools. Toxicity 
of KARs involved in multiple sclerosis has also been found onto oligodendrocytes 
and myelin related to [37, 38], and damage has also been found at axonal levels, 
where AMPA/KARs’ antagonists prevent it [39]. Interestingly, KARs have also been 
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involved in pain. They are present at dorsal roots activating nociceptors, actually 
there are clinical trials using KARs’ antagonists to try to prevent pain showing 
some levels of analgesia [36]. Additionally, KARs have been involved in ischemia 
[40, 41], migraine pain [36], Alzheimer’s disease [42], Parkinson’s disease [43, 44], 
Huntington’s Chorea [45–47], Schizophrenia [48, 49], depression [50], bipolar dis-
order [51, 52], mental retardation [53], and autism [54, 55] as reviewed in [56]. In 
general, antagonists of KARs containing particular subunits might be good targets 
to ameliorate symptoms or treat different CNS diseases and alterations.
2. KARs in the cerebellum
As indicated above, KARs are expressed in the cerebellar cortex [57–59]. As 
known, the cerebellum participates in the modulation of movement by modifying 
the activity patterns of motor neurons. Structurally, the cerebellum is composed 
of the laminar cerebellar cortex and the deep cerebellar nuclei and has five types 
of cells: Purkinje, stellate, basket, Golgi, and granule cells. Purkinje cells (PuC) are 
aligned in front of each other. Their dendritic trees form two 2-dimensional layers 
through which parallel fibers from the mossy fibers located in the granular layer 
pass. These parallel fibers (PF) establish excitatory synapses between granular cells 
and the spines of the PCs dendrites as well as the climbing fibers (CF, originating 
from the inferior olivary nucleus) with the nearby dendrites and the cellular soma. 
The parallel fibers pass orthogonally through the dendritic tree of the Purkinje 
neuron. Up to 200,000 PF form a synapse with a single PuC. Each PuC receives up to 
500 synapses of CF, all originated from a single CF. Both basket cells and stellate cells 
provide an inhibitory (GABAergic) entry to the PuC, with cells in the basket synapse 
to the initial segment of the PuC axon, and stellate cells to the dendrites [60, 61].
Presynaptic KARs participate in plasticity in the cerebellum where PF synapses 
onto PuCs mediate a form of LTD that is affected by the paired activation of CFs 
[62], Table 1; of these two types of fibers (PF and CF synapsing onto the same 
cells (PC), only PF have presynaptic KARs [62], similar to other brain regions as 
somatosensory and visual cortices in which fibers containing and noncontaining 
presynaptic ionotropic glutamate receptors synapse onto the same postsynaptic cell 
and induce LTD [63–69]. The exact role and action mechanism of KARs mediating 
LTD in the cerebellum are not well known yet and await further investigation.
The proper cerebellum development depends on a precise coordinated sequence 
of postnatal events, some of which are mediated by glutamate receptors. For 
example, NMDA receptors have been implicated in the migration of granular 
cells [70] and in the synaptic pruning of climbing fibers [71]. Although it has 
recently been shown that KARs are involved in synaptic transmission, little is 
known about their role in development. However, the expression of kainate-type 
glutamate receptor subunits in immature granule cells of the outer germinal layer 
of the developing cerebellum suggests that KARs may also have a role in neuronal 
maturation. Throughout the maturation process of the cerebellum, the quantity, 
composition, and function of KARs vary. Initially, cerebellar granular cells have a 
minimal amount of AMPARs in the postnatal period compared to KARs, which are 
predominant in immature granule cells. Different studies have shown that KARs 
composed of subunits GluK1, GluK2, and GluK5 predominate, and over the period 
of development, an increase in the number of KARs is observed and once the adult 
stage is reached, the number of KARs containing GluK1 subunits suffers a reduction 
in their expression in the granular layer, while the GluK2 and GluK5 remain con-
stant, in contrast to AMPARs that increase their number, constituting a very notable 
majority compared to KARs.
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All of these findings suggest that KARs have an important role in the develop-
ment process of the cerebellum. Some indications suggest that GluK1-containing 
KARs participate in cerebellar development in the beginning of the differentiation 
of granular cells.
Additionally, KARs have been involved in some brain alterations in the cerebellum 
and a direct relationship exists between KA injection and cerebellar ataxia. Thus, the 
cerebellum is an important target to study functions of KARs and its possible role 
causing ataxia [72–75]. Furthermore, in patients with schizophrenia, an increase in 
KARs containing GluR6 and K2 subunits is observed, which would mediate a reduc-
tion in GABAergic transmission [76, 77]. In neurodegeneration, KARs may have a role 
in calcification of the brain tissue as it has been found that local application of KA in 
some areas of the cerebellum produces changes in different ion levels, highly increas-
ing Ca2+ levels for more than 8 weeks, which mediate calcification [78] (Table 1). 
KARs have been described as producing increases in intracellular calcium [79, 80] and 
seems to signal increasing intracellular calcium without putting the cell at risk due to 
excitotoxicity, due to its low conductance in contrast to AMPARs. Due to the lack of 
knowledge on the subject, further exploration is necessary to determine the KARs’ 
role in cerebellum development and cerebellar alterations.
2.1 KARs modulating glutamate release in the cerebellum: a biphasic effect
KARs are known to be expressed in the cerebellar cortex in the axons of cer-
ebellar granule cells that form PF and make excitatory synapses with PuC [58]. 
Messenger RNA transcripts encoding for different KAR subunits and functional 
expression of KAR subtypes have been reported [81–84]. Biophysical studies with 
single-channel recording have shown GluK1 activity [85], suggesting these KARs 
are Ca2+ permeable. A biphasic action of KARs, activated by the agonist domoate, 
has been shown previously at PF-PuC synapse, with low agonist concentrations, 
facilitating synaptic transmission and higher concentrations depressing synaptic 
KARs’ activation High concentrations 
of kainate
Depression of glutamatergic 
synaptic transmission
Delaney and 
Jahr [86]
Low concentrations 
of kainate
Facilitation of glutamatergic 
synaptic synaptic transmission
Falcón-Moya 
et al. [80]
Ionic imbalance Calcification Korf and 
Postema [78]
Increase in Ca2+ Neurodegeneration
Nodular cerebellum 
lesion
Putrescine increase
Histological damage
Ataxia Maiti et al. [72]
de Vera et al. 
[73]
Yamaguchi 
et al. [74]
Andoh et al. 
[75]
Parallel fibers paired 
with postsynaptic 
depolarization
Presynaptic KARs’ 
activation
Long-term depression Crépel [62]
Increase of GluR6 and 
GluK2 receptors
Reduction of 
GABAergic activity
Schizophrenia Harrison et al. 
[76]
Bullock et al. 
[77]
Table 1. 
KARs’ actions in the cerebellum.
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transmission [86] in agreement with what has been found in the hippocampus 
[87–89], cortex [90], amygdala [91], and the thalamus [92]. EPSC trial-to-trial 
fluctuation analysis, failure rates, as well as paired-pulse ratios have shown that 
these facilitatory and depressive actions of KARs in the cerebellum are mediated by 
presynaptic KARs [80]. However, the precise mechanism of action by which KARs 
mediate potentiation (and depression) of synaptic transmission at PF-PuC synapses 
has remained elusive until very recently [80] (Table 1).
2.1.1  Action mechanism for KARs-mediated facilitation of glutamate release at 
cerebellar PF-PuC synapses
We have recently demonstrated that the effect of the KARs’ activation in this 
synapse requires protein kinase A (PKA) activation, since the inhibition of this 
protein by cAMP-Rp suppresses the effect of KA in glutamate release [80], in agree-
ment with previous studies in hippocampus and cortex [87–89]. This congruence 
between mechanisms at different synapses has also been seen through the inhibition 
of PKA using H-89, which eliminates KARs-mediated facilitation of glutamate 
release. Similarly, the direct activation of AC (adenylyl cyclase) using forskolin 
caused an elimination of facilitation when KARs were activated by KA (with 
NMDARs and AMPARs blocked). These data indicate that a signaling mediated by 
AC/cAMP/PKA supports the facilitation of the modulation of synaptic transmis-
sion/glutamate release in these cerebellar synapses (Figures 1–3).
As observed in other synapses, Ca2+ seems to play a fundamental role in facilitat-
ing glutamate release at PF-PuC synapses. By blocking calcium-permeable KARs 
by the selective inhibitor philanthotoxin, KAR-mediated synaptic facilitation of 
glutamate release was prevented, indicating that there is a strict requirement for 
external Ca2+ entry through KARs to support the facilitation effect observed on 
glutamate release, indicating that KARs mediating the facilitation of glutamate 
release are calcium permeable [80].
Additionally, as has been reported at hippocampal synapses, the depletion of 
intracellular Ca2+ stores by a treatment with thapsigargin (a noncompetitive cal-
cium inhibitor of the sarcoplasmic reticulum ATPase) eliminates the facilitation of 
glutamate release mediated by KARs’ activation. The same result was found when 
selectively inhibiting Ca2+-induced calcium release by using ryanodine, indicating 
that the entry of Ca2+ via KARs induces a mobilization of Ca2+ from the intratermi-
nal Ca2+ reserves to mediate the increase in glutamate release observed [80].
Furthermore, it has been observed that the facilitation of glutamate release 
mediated by the activation of KARs is sensitive to calmodulin inhibitors. Previous 
studies showed that the increase of cytosolic calcium levels activates Ca2+ depen-
dent on AC present in the terminals of parallel fibers. Through treatment with the 
calmodulin inhibitors, W-7 and calmidazolium, it has been recently shown [80] that 
the inhibition of calcium-calmodulin function prevents KAR-mediated presynaptic 
facilitation of glutamate release in cerebellar slices, supporting the hypothesis 
that after KAR activation and cytosolic elevation of Ca2+, a calmodulin-dependent 
calcium coupling activates AC, which subsequently activates the AC/cAMP/PKA 
pathway, thus promoting synaptic facilitation through an increase in neurotrans-
mitter release at PF-PuC synapses [80].
2.1.2  Action mechanism for KARs-mediated depression of glutamate release at 
cerebellar PF-PuC synapses
Recently, in the same study discussed in the previous section [80], a transient 
synaptic depression of glutamate release with high concentrations of KA (3 μM) 
7Kainate Receptors Modulating Glutamate Release in the Cerebellum
DOI: http://dx.doi.org/10.5772/intechopen.87984
was observed as reported for other different brain areas including thalamus, cortex, 
hippocampus, and amygdala [89–92]. This depression of glutamate release was pre-
vented in the presence of cAMP-RP (which inhibits the activation of PKA), but was 
not affected by any other experimental modification discussed above with respect 
to the facilitation of glutamate release. This fact may indicate that the synaptic 
depression is probably related to an AC/cAMP/PKA signaling pathway (as for facili-
tation of glutamate release), but without the coupling of Ca2+ to the AC. Therefore, 
Figure 1. 
KAR-mediated facilitation of glutamate release involving activation of adenylyl cyclase (AC) and downstream 
protein kinase A (PKA) at PF-PuC synapses of the cerebellum. (A) Time course of KA (3 μM) effect on 
eEPSCs amplitude in the absence (circles) and presence of NBQX (squares). Insets show traces before and after 
4 min of KA perfusion in the absence (1, 2) and in the presence of 10 μM NBQX (1′, 2′). (B) Quantification of 
modulation observed in (A) and dose-response curve. (C) Time course of the effect of KA on eEPSC amplitude 
in cAMP-Rp-treated slices. (D) Inhibition of PKA by cAMP-Rp (100 μM) or H-89 (2 μM), and activation of 
AC by forskolin (30 μM) prevented the facilitatory action of KA. Inhibition of PKC with calphostin C (1 μM) 
has no effect on the KA enhancement of the eEPSC amplitude. The facilitatory effect of KA is not affected in 
slices treated with pertussis toxin. Modified from [64].
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KA receptors have alternative mechanisms for facilitating and depressing glutamate 
release at PF-Pu synapses (Figures 1–3). In previous studies, investigating mossy 
fiber-CA3 hippocampal synapses [88, 89, 93, 94], as well as the amygdala [37] and 
cortex [36], a similar mechanism has been observed additionally involving the 
activation of a G-protein for the depressive effect that may well be also the case for 
these cerebellar synapses.
Although the presynaptic function of KARs facilitating glutamate release 
implies an increase in AC/cAMP/PKA signaling induced by the calcium calmodulin 
complex, KARs appear to be negatively associated with this pathway to carry out 
synaptic transmission of depression. Previous studies at hippocampal MF-CA3 
Figure 2. 
Facilitation of glutamate release mediated by KAR activation requires an increase of Ca2+ in the cytosol and 
Ca2+ calmodulin at cerebellar PF-PuC synapses. (A) Time course of KA (3 μM) effect on eEPSCs amplitude 
in control condition (circles) and in slices treated with philanthotoxin (squares). (B) Quantification of 
modulation observed in (A). (C) Time course of KA (3 μM) effect on eEPSCs amplitude in control condition 
(circles) and in the slices treated with 25 μM W-7 (squares). (D) Quantification of modulation observed in 
(A) and in the presence of 1 μM CMZ. Modified from [64].
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synapses and thalamocortical synapses, as well as at PF-PuC synapses, have 
reported that the depression of glutamate release mediated by presynaptic KARs 
occurs through a negative coupling to the AC/cAMP/PKA pathway, being actually 
evoked by the action of a PTx-sensitive protein G [80, 88, 92]. Despite the hypoth-
eses discussed above, it is also possible that these observed mechanisms reflect 
the presence of two different types of KARs, a clear objective being to clarify this 
hypothesis in future studies.
3. Conclusions
Regarding the role and mechanisms of KARs in the modulation of glutamate 
release in the cerebellum, new and recent data indicate that the KARs effecting 
facilitation of glutamate release and synaptic transmission show a mandatory 
dependence on adenylyl cyclase (AC) and cAMP-mediated protein kinase A (PKA) 
activity. Furthermore, the KAR-mediated facilitation of transmission is contingent 
on both external Ca2+ permeation into the cytosol through KAR and repletion of 
Figure 3. 
KAR-mediated modulation of glutamate release in the cerebellum. Actions of KARs depressing or facilitating 
glutamate release at the PF-PuC synapse. KAR activation by high concentrations of KA (>3 μM) depresses 
glutamate release at PF-PuC synapses, an effect that involves Gi/o protein and the adenylate cyclase/cAMP/
protein kinase A (AC/cAMP/PKA) pathway. KAR activation by low concentrations of kainate (<0.3 μM) only 
facilitates glutamate release following activation of a Ca2+-calmodulin/AC/cAMP/PKA pathway.
Biogenic Amines in Neurotransmission and Human Disease
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intracellular Ca2+ stores. Finally, a major sensitivity of facilitation to calmodulin 
inhibition suggests that KARs are coupled through a Ca2+-calmodulin/AC/cAMP/
PKA pathway at PF-PuC synapses in the cerebellum. KARs seem to use the inhibi-
tion of the AC/cAMP/PKA pathway to mediate a depression of glutamate release at 
the same synapses, but the activation of the AC does not involve calcium calmodu-
lin and seems to be directly activated by a PTX-sensitive G protein.
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